Scaling selective cross-border buy-and-build
Axcel appears to be intensifying a selective buy‑and‑build approach across its portfolio platforms, using add‑on acquisitions and financing to expand into adjacent European markets while keeping its core fund focus on the Nordics and DACH.
Public signs include multiple platform acquisitions and expansions, a fund strategy that emphasizes selective cross‑border growth, and dedicated financing for add‑on deals.
-
Vinge advised Axcel and Sanviva on the acquisitions of DermaCura and YourRad, indicating continued add‑on activity under Axcel ownership.
-
Fund‑closing materials for Axcel VIII describe the fund's investment strategy as focused on the Nordics and DACH, suggesting selective cross‑border expansion.
-
Accru announced a EUR 550 million senior secured bond and a EUR 125 million revolving credit facility, with proceeds available to support future add‑on acquisitions.
-
Accru's latest‑news feed shows that the Axcel‑backed platform expanded into France in August 2026.
-
Axcel‑backed XPartners reported acquiring nine companies during Q2 and two more shortly after, including Corall Ingenieure in Germany.